Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorKorea University Anam Hospital
About this trial
The correlation of coronary microvascular function and body composition with cardiopulmonary exercise capacity will be assessed in patients with heart failure with preserved ejection fraction.
Eligibility criteria
Qualifiers
Age 20 to 80
Typical/atypical chest pain or ischemic symptoms including dyspnea
No significant coronary artery stenosis (>50% stenosis) in coronary angiography or computed tomography
Left ventricular ejection fraction ≥50%
Disqualifiers
More than moderate valvular heart disease
Congenital heart disease
Chronic renal failure (estimated glomerular filtration rate <30 ml/min/1.73m2) or end-stage renal failure undergoing hemodialysis or peritoneal dialysis
Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension
Trial design
Treatments tested in this trial
- Adenosine stress echocardiography with the evaluation of coronary artery blood flow
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
1Korea University Anam Hospital Seoul South Korea
Sponsors and collaborators
Korea University Anam Hospital
Lead sponsor
Source ClinicalTrials.gov